Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-17

There is potentially quite a huge rabbit in the hat to pull out .

Worth looking at a few of the recent vids with the new COO & also worth checking out her background

As well worth trying to get a bit of an understanding as to exactly what CHM are doing - its pure R& D at the moment - but in a field where some of the valuations of similar /like type of treatments and therapies have attracted extremely high valuations

The stock originally listed at 20 cents a share ..... a few years back .... they have raised capital ....a couple of times ..... like a number of companies like this they are pretty well shunned by the market .

A lot more to the story ....and worth understanding

The board has recently made provision to expand the issue X approx 100% --which will take SoI to approx 1.6-1.7 Bill .. ... I suspect IF all tnse shares are taken up they will be a major corner stone investor .... and probably wont be at much of a premium to the current pricing range ...unless there is some brilliant salesmanship done by the current board/ seniour managements . Probably doesn't matter much in the long run if the stock is taken up at current prices , a bit less or a bit more ..... so long its take up bu a player in the field .

Just so long as there is fuel in the tank ....for the next year or so

IF the current line of R& D produce the data many think they will ..... then iis not beyond the realm of reason to put a price tag on developing IP asset way way higher ....could even be 10 20 times who knows .

IF it all sounds like BS ... thats OK & maybe not for you

Dont bet the house ..... but a garage could well be an interesting outcome .

cheers